TY - JOUR
T1 - Neodymium-yag laser vitreolysis in sickle cell retinopathy
AU - Hrisomalos, Nick F.
AU - Jampol, Lee M.
AU - Moriarty, Brendan J.
AU - Serjeant, Graham
AU - Acheson, Robert
AU - Goldberg, Morton F.
N1 - Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 1987/8
Y1 - 1987/8
N2 - Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.
AB - Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.
UR - http://www.scopus.com/inward/record.url?scp=0023256755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023256755&partnerID=8YFLogxK
U2 - 10.1001/archopht.1987.01060080089034
DO - 10.1001/archopht.1987.01060080089034
M3 - Article
C2 - 3632418
AN - SCOPUS:0023256755
SN - 0003-9950
VL - 105
SP - 1087
EP - 1091
JO - Archives of ophthalmology
JF - Archives of ophthalmology
IS - 8
ER -